future of glp-1 drugs Drugs: Where We Are and Where We're Going β Summit Re π Listen to this essay:
Description
The phase 2 trial published in the New England Journal of Medicine documented heart rate increases across every dose group
It is essential to conduct basic and translational research to investigate the neural and systemic effects of GLP-1 agonists further, particularly in people with obesity, disordered eating 33 , or addiction
indicates enhancements in -cell functionality via decreased endoplasmic reticulum stress and augmented proliferation and survival signalling (Meloni et al
doi: 10.1016/j.cmet.2018.03.001
This rapid glucose lowering can also induce hypoxia, which may modulate the effect of GLP-1 RAs on retinal VEGF expression [100]
